Jill Howe

Jill Howe

Chief Financial Officer, DTx

Jill Howe brings her extensive finance background to inform Codagenix’s internal financial strategy. Howe has served as the Chief Financial Officer of DTx since June 2021, a role to which she brings more than 20 years of experience in the biotechnology sectors in operation and financial strategy, treasury, global infrastructure and compliance management. Prior to joining DTx, Howe was the Treasurer and Vice President of Finance at Gossamer Bio, where she was the internal project lead for the company’s initial public offering, follow-on, and debt offerings and oversaw finance for 18 subsidiaries across the U.S. and Ireland. She previously held Controller and Director of Finance roles at Amplyx Pharmaceuticals, Receptos Inc. and Somaxon Pharmaceuticals.

Back to Jill Howe